Cargando…
Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis
BACKGROUND: Dll4/Notch and Ephrin-B2/EphB4 pathways play critical roles in tumor vessel development and maturation. This study evaluates the efficacy of the inhibition of both signaling pathways, alone and in combination, in reducing the growth of an autochthonous mouse tumor and assesses potential...
Autores principales: | Djokovic, Dusan, Trindade, Alexandre, Gigante, Joana, Badenes, Marina, Silva, Lilliana, Liu, Ren, Li, Xiuqing, Gong, Ming, Krasnoperov, Valery, Gill, Parkash S, Duarte, Antonio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3001720/ https://www.ncbi.nlm.nih.gov/pubmed/21092311 http://dx.doi.org/10.1186/1471-2407-10-641 |
Ejemplares similares
-
EphB4/EphrinB2 therapeutics in Rhabdomyosarcoma
por: Randolph, Matthew E., et al.
Publicado: (2017) -
EphB4 as a therapeutic target in mesothelioma
por: Liu, Ren, et al.
Publicado: (2013) -
The Differential Expression of EphB2 and EphB4 Receptor Kinases in Normal Bladder and in Transitional Cell Carcinoma of the Bladder
por: Li, Xiuqing, et al.
Publicado: (2014) -
Low-Dosage Inhibition of Dll4 Signaling Promotes Wound Healing by Inducing Functional Neo-Angiogenesis
por: Trindade, Alexandre, et al.
Publicado: (2012) -
EphrinB2–EphB4 Signaling in Neurooncological Disease
por: Piffko, Andras, et al.
Publicado: (2022)